Neuland Laboratories Limited, headquartered in Hyderabad, India, is a leading manufacturer and distributor of active pharmaceutical ingredients (APIs). With a presence in India, Europe, the United States, and other international markets, the company offers a wide range of APIs used in various therapeutic areas. These include antiasthmatics, cardiovasculars, antifungal, anticonvulsants, central nervous system, fluoroquinolones, antipsychotic, antibacterial, and anti-parkinson medications. In addition to its API portfolio, Neuland Laboratories Limited also specializes in custom manufacturing solutions and provides peptide synthesis services. Established in 1984, the company has built a strong reputation for its quality products and commitment to the pharmaceutical industry.
Navigation section
Neuland Laboratories Limited
- 16,820.40 -231.15(-1.36%) 16,848.00 -198.20(-1.16%)
Performance
| Today's Low | Today's High | |
|---|---|---|
| 16,587.50 16,578.85 | 17,051.55 17000.00 |
| 52 Week Low | 52 Week High | |
|---|---|---|
| 4,926.05 (21-Dec-2023) 4,928.00 (21-Dec-2023) | 18,100.00 (04-Dec-2024) 18,089.55 (04-Dec-2024) |
- Open
- 17,051.55 16,931.10
- Previous Close
- 17,051.55 17,046.20
- Volume
- 0.39
- Total Traded value
- 65.96 (₹ Lakhs)
- Upper circuit
- 20,461.85 6,828.15
- Lower circuit
- 13,641.25 4,552.15
Market Depth
| Buy Order Quantity | Sell Order Quantity | |
|---|---|---|
| 0 | 0 |
| Bid Price | Quantity |
|---|---|
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | -- |
| Ask Price | Quantity |
|---|---|
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | -- |
Fundamentals
| Market Cap: | ₹215.80 Cr |
| PE Ratio (TTM): | 77.59 |
| PB Ratio: | 15.57 |
| Industry P/E: | 82.90 |
| Debt to Equity: | - |
| ROE: | 20.07 |
| EPS (TTM): | 217.15 |
| Book Value: | 0.00 |
| Face Value: | 10.00 |
Financials
| Jun, 2023 | Jun, 2023 | Jun, 2023 | Jun, 2023 | Jun, 2023 | |
|---|---|---|---|---|---|
| Revenue | 280.33 Cr | 1,690.18 Cr | 90.16 Cr | 42.29 Cr | 362.99 Cr |
| Profit | 21.56 Cr | 368.40 Cr | -5.99 Cr | -0.83 Cr | 62.22 Cr |
| Expense | 251.52 Cr | 1,233.46 Cr | 97.02 Cr | 41.97 Cr | 281.53 Cr |
| Comprehensive income | 21.33 Cr | 368.10 Cr | -5.98 Cr | -0.83 Cr | 62.26 Cr |
| EPS | 17.59 | 37.30 | -4.62 | -0.02 | 48.50 |
| Company name | Listing date | Industry | NSE symbol BSE symbol |
|---|---|---|---|
| Neuland Laboratories Limited | Oct, 2008 Jul, 1994 | Pharmaceuticals Pharmaceuticals | NEULANDLAB NEULANDLAB |
Shareholding pattern
Sep, 2023 Jun, 2023 Mar, 2023 Dec, 2022 Sep, 2022
Neuland Laboratories Limited FAQ's
What is the range of today's stock performance for Neuland Laboratories Limited?
Today's stock performance witnessed a fluctuation from a minimum of 16,587.50 on the NSE (National Stock Exchange) to a maximum of 17,051.55. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 16,578.85 to a high of 17,000.00.
What are the 52-week low and high values for Neuland Laboratories Limited?
The stock's performance over the past 52 weeks reveals a low of 4,926.05 (occurred on 21-Dec-2023) and a high of 18,100.00 (achieved on 04-Dec-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 4,928.00 (on 21-Dec-2023), and the 52-week high is 18,089.55 (on 04-Dec-2024).
What was the opening and previous closing prices for Neuland Laboratories Limited?
The stock's performance over the past 52 weeks reveals a low of 4,926.05 (occurred on 21-Dec-2023) and a high of 18,100.00 (achieved on 04-Dec-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 4,928.00 (on 21-Dec-2023), and the 52-week high is 18,089.55 (on 04-Dec-2024).
What is the total volume and traded value for Neuland Laboratories Limited for the day?
The total volume is 0, and the total traded value is 65.96 (₹ Lakhs).
What are the upper and lower circuit limits for Neuland Laboratories Limited?
The upper circuit limit is 20,461.85, and the lower circuit limit is 13,641.25.
What is the market cap and PE ratio for Neuland Laboratories Limited?
The market cap is ₹215.80 Cr, and the PE ratio (TTM) is 78.22.
What are the financial metrics such as ROE, EPS, dividend yield, book value, and face value for Neuland Laboratories Limited?
ROE is 20.07, EPS is 217.15, book value is not available
What are the revenue and profit figures for the latest quarter and previous quarters for Neuland Laboratories Limited?
In Jun 2023, Revenue is ₹2803300000.00, and Profit is ₹215600000.00. In Jun 2023, Revenue is ₹16901800000.00, and Profit is ₹3684000000.00.
When was Neuland Laboratories Limited listed, and what industry does it belong to?
The company, Neuland Laboratories Limited, was listed in Oct 2008 and belongs to the Pharmaceuticals industry. Its NSE symbol is NEULANDLAB.
What is the current shareholding pattern of the Neuland Laboratories Limited?
As of latest available update, promoters hold 35.97%, the public holds 64.03%, and Employee Trusts holds 0.00.
The Indian Community
Public Community
Settings
Discover the vibrant tapestry of 'The Indian Community' - a melting pot of diverse cultures, traditions, and values. Explore its rich heritage, festivals, and contributions, as this online hub celebrates the essence of India's people, connecting, inspiring, and fostering unity worldwide.
- Members
- 29
- Threads
- 96
